Early treatment of depressive symptoms and long-term survival after liver transplantation

American Journal of Transplantation

Volumn 13, Issue 4, 2013, Pages 928-935

  Rogal, S S ^a   Dew, M A ^a   Fontes, P ^b   Dimartini, A F ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Alcoholism; antidepressants; cirrhosis

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; BECK DEPRESSION INVENTORY; DEPRESSION; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; LIVER TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL;

ADULT; ANTIDEPRESSIVE AGENTS; COHORT STUDIES; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84875735732     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12164     Document Type: Article

References (33)

1. Singh N, Gayowski T, Wagener MM, Marino IR,. Depression in patients with cirrhosis. Impact on outcome. Dig Dis Sci 1997; 42: 1421-1427. (Pubitemid 27339357)
2. DiMartini A, Dew MA, Chaiffetz D, Fitzgerald MG, Devera ME, Fontes P,. Early trajectories of depressive symptoms after liver transplantation for alcoholic liver disease predicts long-term survival. Am J Transplant 2011; 11: 1287-1295.
3. Fortes C, Mastroeni S, Alessandra S, et al. The combination of depressive symptoms and smoking shorten life expectancy among the aged. Int Psychogeriatr 2011: 1-7.
4. Sullivan MD, O'Connor P, Feeney P, et al. Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy. Diabetes Care 2012; 35: 1708-1715.
5. Diez-Quevedo C, Lupon J, Gonzalez B, et al. Depression, antidepressants, and long-term mortality in heart failure. Int J Cardiol 2012 Apr 14 [Epub ahead of print].
6. Blumenthal JA, Lett HS, Babyak MA, et al. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 2003; 362: 604-609. (Pubitemid 37013300)
7. Corruble E, Barry C, Varescon I, Falissard B, Castaing D, Samuel D,. Depressive symptoms predict long-term mortality after liver transplantation. J Psychosom Res 2011; 71: 32-37.
8. OPTN/SRTR 2009 Annual Report: U.S. Department of Health & Human Services; 2009 [cited 2012 June 4]. Available from: http://optn.transplant.hrsa. gov/ar2009/910a-li.pdf.
9. Dew MA, DiMartini AF, DeVito Dabbs AJ, et al. Onset and risk factors for anxiety and depression during the first 2 years after lung transplantation. Gen Hosp Psychiatry 2012; 34: 127-138.
10. Rogal SS, Landsittel D, Surman O, Chung RT, Rutherford A,. Pretransplant depression, antidepressant use, and outcomes of orthotopic liver transplantation. Liver Transpl 2011; 17: 251-260.
11. Beck AT, Guth D, Steer RA, Ball R,. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Therapy 1997; 35: 785-791. (Pubitemid 27336913)
12. Sackeim HA,. The definition and meaning of treatment-resistant depression. J Clin Psychiatry 2001; 62 (Suppl 16): 10-17.
13. Kocsis JH, Gelenberg AJ, Rothbaum B, et al. Chronic forms of major depression are still undertreated in the 21st century: Systematic assessment of 801 patients presenting for treatment. J Affect Disord 2008; 110: 55-61.
14. Sobell LC, Sobell MB,. Timeline Follow-Back: A Technique for Assessing Self-Reported Alcohol Consumption, Measuring Alcohol Consumption. Totowa, NJ: The Humana Press, Inc., 1992.
15. Hollingshead ADB, Redlich FC,. Social Class and Mental Illness; a Community Study. New York: Wiley, 1958, pp. ix, 442.
16. Charlson M, Szatrowski TP, Peterson J, Gold J,. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47: 1245-1251. (Pubitemid 24361532)
17. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997; 25: 658-663.
18. Grant BF, Harford TC,. Comorbidity between DSM-IV alcohol use disorders and major depression: Results of a national survey. Drug Alcohol Depend 1995; 39: 197-206.
19. Smoller JW, Allison M, Cochrane BB, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med 2009; 169: 2128-2139.
20. Tata LJ, West J, Smith C, Farrington P, et al. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart 2005; 91: 465-471. (Pubitemid 40432771)
21. Cohen HW, Gibson G, Alderman MH,. Excess risk of myocardial infarction in patients treated with antidepressant medications: Association with use of tricyclic agents. Am J Med 2000; 108: 2-8. (Pubitemid 30058271)
22. Scherrer JF, Garfield LD, Lustman PJ, et al. Antidepressant drug compliance: Reduced risk of MI and mortality in depressed patients. Am J Med 2011; 124: 318-324.
23. Scherrer JF, Chrusciel T, Garfield LD, et al. Treatment-resistant and insufficiently treated depression and all-cause mortality following myocardial infarction. Br J Psychiatry 2012; 200: 137-142.
24. Sherwood A, Blumenthal JA, Trivedi R, et al. Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 2007; 167: 367-373. (Pubitemid 46333937)
25. O'Connor CM, Jiang W, Kuchibhatla M, et al. Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med 2008; 168: 2232-2237.
26. O'Connor CM, Jiang W, Kuchibhatla M, et al. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 2010; 56: 692-699.
27. Antonioli M, Rybka J, Carvalho LA,. Neuroimmune endocrine effects of antidepressants. Neuropsychiatr Dis Treat 2012; 8: 65-83.
28. Wei JF, Zheng SS,. NF-kappa B in allograft rejection. Hepatobiliary Pancreat Dis Int 2003; 2: 180-183.
29. Berberat PO, Friess H, Schmied B, et al. Differentially expressed genes in postperfusion biopsies predict early graft dysfunction after liver transplantation. Transplantation 2006; 82: 699-704. (Pubitemid 44395242)
30. Tian Y, Graf R, El-Badry AM, et al. Activation of serotonin receptor-2B rescues small-for-size liver graft failure in mice. Hepatology 2011; 53: 253-262.
31. Diaz SL, Doly S, Narboux-Neme N, et al. 5-HT(2B) receptors are required for serotonin-selective antidepressant actions. Mol Psychiatry 2012; 17: 154-163.
32. Liu SS, Schneekloth TD, Talwalkar JA, et al. Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C. J Clin Gastroenterol 2010; 44: e178-e185.
33. Lopez-Navas A, Rios A, Moya-Faz FJ, et al. Emotional-type psychopathologic symptoms among patients with terminal chronic alcohol-induced liver cirrhosis. Transplant Proc 2012; 44: 1510-1512.